Common Heart Drug Repurposed to Treat Rare Cancer in Europe (VIDEO)

Texas Tech University Health Sciences Center El Paso

Caption

A drug that's commonly used to treat high blood pressure is being repurposed for a rare tissue cancer in Europe. The medication, named propranolol, was recently granted Orphan Drug Designation by the European Commission (EC). Here, biomedical Scientist Brad Bryan, Ph.D., who has published several papers on the drug, discusses his work with propranolol and soft tissue sarcomas.

Credit

Texas Tech University Health Sciences Center El Paso

Usage Restrictions

Credit Required.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.